Repatha ® Active substance Evolocumab Holder Amgen Status Closed Indication severe uncontrolled familial hypercholesterolemia (FH), despite treatment with a maximum tolerated dose of a statin in combination with ezetimibe, or with ezetimibe without a statin in case of statin intolerance or contra‐indication Public documents Initial Approbation Approbation of the amendement Information for the patient Informed consent Last update 30/05/2017